1-5 of 5
Paola Tomassetti
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Risk and Protective Factors for Small Intestine Neuroendocrine Tumors: A Prospective Case-Control Study

Available to Purchase
Subject Area:
Endocrinology , Neurology and Neuroscience
Maria Rinzivillo, Gabriele Capurso, Davide Campana, Nicola Fazio, Francesco Panzuto, Francesca Spada, Noemi Cicchese, Stefano Partelli, Paola Tomassetti, Massimo Falconi, Gianfranco Delle Fave
Journal: Neuroendocrinology
Neuroendocrinology (2016) 103 (5): 531–537.
https://doi.org/10.1159/000440884
Published Online: 10 September 2015
View articletitled, Risk and Protective Factors for Small Intestine Neuroendocrine Tumors: A Prospective Case-Control Study
Open the PDF for Risk and Protective Factors for Small Intestine Neuroendocrine Tumors: A Prospective Case-Control Study in another window
Journal Articles

ENETS Consensus Guidelines for the Management of Patients with Gastroduodenal Neoplasms

Available to Purchase
Subject Area:
Endocrinology , Neurology and Neuroscience
Gianfranco Delle Fave, Dik J. Kwekkeboom, Erik Van Cutsem, Guido Rindi, Beata Kos-Kudla, Ulrich Knigge, Hironobu Sasano, Paola Tomassetti, Ramon Salazar, Philippe Ruszniewski, all other Barcelona Consensus Conference participants
Journal: Neuroendocrinology
Neuroendocrinology (2012) 95 (2): 74–87.
https://doi.org/10.1159/000335595
Published Online: 29 December 2011
View articletitled, ENETS Consensus Guidelines for the Management of Patients with Gastroduodenal Neoplasms
Open the PDF for ENETS Consensus Guidelines for the Management of Patients with Gastroduodenal Neoplasms in another window
Journal Articles

Risk Factors for Disease Progression in Advanced Jejunoileal Neuroendocrine Tumors

Available to Purchase
Subject Area:
Endocrinology , Neurology and Neuroscience
Francesco Panzuto, Davide Campana, Nicola Fazio, Maria Pia Brizzi, Letizia Boninsegna, Francesca Nori, Giovanni Di Meglio, Gabriele Capurso, Aldo Scarpa, Luigi Dogliotti, Filippo De Braud, Paola Tomassetti, Gianfranco Delle Fave, Massimo Falconi
Journal: Neuroendocrinology
Neuroendocrinology (2012) 96 (1): 32–40.
https://doi.org/10.1159/000334038
Published Online: 28 December 2011
View articletitled, Risk Factors for Disease Progression in Advanced Jejunoileal Neuroendocrine Tumors
Open the PDF for Risk Factors for Disease Progression in Advanced Jejunoileal Neuroendocrine Tumors in another window
Journal Articles

Endocrine Tumors of the Ileum: Factors Correlated with Survival

Available to Purchase
Subject Area:
Endocrinology , Neurology and Neuroscience
Paola Tomassetti, Davide Campana, Lydia Piscitelli, Riccardo Casadei, Francesca Nori, Emilio Brocchi, Donatella Santini, Raffaele Pezzilli, Roberto Corinaldesi
Journal: Neuroendocrinology
Neuroendocrinology (2006) 83 (5-6): 380–386.
https://doi.org/10.1159/000096053
Published Online: 13 November 2006
View articletitled, Endocrine Tumors of the Ileum: Factors Correlated with Survival
Open the PDF for Endocrine Tumors of the Ileum: Factors Correlated with Survival in another window
Journal Articles

Rapid and Sustained Relief from the Symptoms of Carcinoid Syndrome: Results from an Open 6-Month Study of the 28-Day Prolonged-Release Formulation of Lanreotide

Available to Purchase
Subject Area:
Endocrinology , Neurology and Neuroscience
Philippe Ruszniewski, Sofia Ish-Shalom, Machteld Wymenga, Dermot O’Toole, Rudolf Arnold, Paola Tomassetti, Nigel Bax, Martyn Caplin, Barbro Eriksson, Benjamin Glaser, Michel Ducreux, Catherine Lombard-Bohas, Wouter W. de Herder, Gianfranco Delle Fave, Nick Reed, Jean François Seitz, Eric van Cutsem, Ashley Grossman, Philippe Rougier, Wolfgang Schmidt, Bertram Wiedenmann
Journal: Neuroendocrinology
Neuroendocrinology (2005) 80 (4): 244–251.
https://doi.org/10.1159/000082875
Published Online: 25 January 2005
View articletitled, Rapid and Sustained Relief from the Symptoms of Carcinoid Syndrome: Results from an Open 6-Month Study of the 28-Day Prolonged-Release Formulation of Lanreotide
Open the PDF for Rapid and Sustained Relief from the Symptoms of Carcinoid Syndrome: Results from an Open 6-Month Study of the 28-Day Prolonged-Release Formulation of Lanreotide in another window